DrugPatentWatch Database Preview
Central Radiopharm Company Profile
Email this page to a colleague
» See Plans and PricingWhat is the competitive landscape for CENTRAL RADIOPHARM, and what generic and branded alternatives to CENTRAL RADIOPHARM drugs are available?
CENTRAL RADIOPHARM has one approved drug.
Summary for Central Radiopharm
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Central Radiopharm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Central Radiopharm | AMMONIA N 13 | ammonia n-13 | INJECTABLE;INTRAVENOUS | 204539-001 | Jun 23, 2015 | DISCN | No | No | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
